| __timestamp | HUTCHMED (China) Limited | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 33472000 | 1488000000 |
| Thursday, January 1, 2015 | 47368000 | 1525000000 |
| Friday, January 1, 2016 | 66871000 | 2111000000 |
| Sunday, January 1, 2017 | 50675000 | 1848000000 |
| Monday, January 1, 2018 | 78821000 | 1213000000 |
| Tuesday, January 1, 2019 | 91944000 | 1010000000 |
| Wednesday, January 1, 2020 | 111234000 | 997000000 |
| Friday, January 1, 2021 | 207447000 | 967000000 |
| Saturday, January 1, 2022 | 267587000 | 838000000 |
| Sunday, January 1, 2023 | 303055000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and HUTCHMED (China) Limited have taken distinct paths in their R&D investments.
Teva, a global leader, has consistently allocated substantial resources to R&D, peaking in 2016 with a 63% increase from 2014. Despite a slight decline in recent years, Teva's R&D spending remains robust, reflecting its commitment to maintaining a competitive edge.
In contrast, HUTCHMED has shown a remarkable upward trajectory, with R&D expenses growing nearly tenfold from 2014 to 2023. This surge underscores HUTCHMED's aggressive strategy to expand its footprint in the pharmaceutical industry.
Both companies exemplify different strategies in navigating the ever-evolving landscape of pharmaceutical innovation.
Novo Nordisk A/S or HUTCHMED (China) Limited: Who Invests More in Innovation?
Johnson & Johnson or HUTCHMED (China) Limited: Who Invests More in Innovation?
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
Sanofi vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
R&D Insights: How Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited Allocate Funds
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Genmab A/S vs HUTCHMED (China) Limited
Comparing Innovation Spending: Ascendis Pharma A/S and HUTCHMED (China) Limited
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Investment: HUTCHMED (China) Limited vs Xencor, Inc.